home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

NGS Solutions for FFPE Materials — Maximizing Immuno-Oncology Insights with Challenging Clinical Samples

 
  October 25, 2022  
     
 
Xtalks, online
2022 -12-15


Formalin-fixed biological specimens are an invaluable resource for the extraction of DNA, RNA and protein. By providing information on single-gene mutations through next-generation sequencing (NGS) processes, FFPE (Formalin-Fixed Paraffin-Embedded) samples enable precision medicine and cancer genetics studies. In addition, FFPE tissues are more readily available and easier to handle in clinical practice than fresh frozen tissues. However, the physical and chemical modifications following formalin fixation can pose difficulties — such as DNA degradation, cross-linking and fragmentation — for NGS processes.
 
In this webinar, the featured speaker shares insights into FFPE fixation conditions, quality metrics that are most predictive of success, and how to leverage assay design when working with these precious specimens. Highlights of the Personalis clinical laboratory experience in providing robust genomic solutions for clinical research and diagnostic applications from both limited and challenging studies will be presented.
 
Register for this webinar to gain insights into maximizing immuno-oncology insights for challenging clinical samples with NGS solutions.
 
 
Organized by: Xtalks
Invited Speakers: Erin N. Newburn, MS, PhD, Director, Field Applications Scientist, Personalis, Inc.
 
Deadline for Abstracts: 2022 -12-15
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2022 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.